Reversal gene expression assessment for drug repurposing, a case study of glioblastoma
Abstract Background Glioblastoma (GBM) is a rare brain cancer with an exceptionally high mortality rate, which illustrates the pressing demand for more effective therapeutic options. Despite considerable research efforts on GBM, its underlying biological mechanisms remain unclear. Furthermore, none...
Saved in:
Main Authors: | Shixue Sun, Zeenat Shyr, Kathleen McDaniel, Yuhong Fang, Dingyin Tao, Catherine Z. Chen, Wei Zheng, Qian Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-06046-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
by: Arnob Sarker, et al.
Published: (2025-01-01) -
Comprehensive evaluation of pure and hybrid collaborative filtering in drug repurposing
by: Clémence Réda, et al.
Published: (2025-01-01) -
High-throughput tracking enables systematic phenotyping and drug repurposing in C. elegans disease models
by: Thomas J O'Brien, et al.
Published: (2025-01-01) -
HEDDI-Net: heterogeneous network embedding for drug-disease association prediction and drug repurposing, with application to Alzheimer’s disease
by: Yin-Yuan Su, et al.
Published: (2025-02-01)